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Background: Previously, we demonstrated that trans fatty acid ingestion during pregnancy and lactation caused a
pro-inflammatory effect on the newborn. The opposite effect was described for gestational prebiotic intake. In the
present study, we examined whether supplementation of the diet of the dams with 10% of oligofructose with or
without hydrogenated vegetable fat during pregnancy and lactation affected the pro-inflammatory status on the
pups at age 21 days.
Methods: On the first day of pregnancy, rats were divided into four groups, each of which received one of four
diets: a control diet (C group), a control diet supplemented with 10% oligofructose (CF group), a diet enriched with
hydrogenated vegetable fat containing trans fatty acids (T group) or a diet enriched with hydrogenated vegetable
fat containing trans fatty acids supplemented with 10% oligofructose (TF group). The pups were weighed at birth
and at 7, 14 and 21 days of life and were euthanized on post-natal day 21. The serum glucose, insulin and
adiponectin concentrations were analyzed. The IL-6, IL-10 and TNF-α contents of the retroperitoneal white adipose
tissue, liver, soleus and extensor digital longus muscles were analyzed by ELISA. The results are presented as the
means ± standard error of the mean. Statistical significance was assessed using two-way ANOVA, followed by
Tukey's test and considered significant at p < 0.05
Results: The body weights of the 21-day old pups in the CF and TF groups were significant lower than those of
the C (27% and 21%) and T (25% and 19%, respectively) groups. The serum levels of adiponectin in the CF, T and
TF groups were lower than in the C group (41%; 34% and 31%, respectively). In the retroperitoneal adipose tissue,
the IL-6 content was increased in TF group relative to the C and CF groups (74% for both), and the TNF-α content
was higher in the T and TF groups than in the C group (62% and 98%, respectively). In the liver, the TNF-α (56%
and 104%) and IL-10 (52% and 73%) contents were increased in the CF group relative to the C and TF groups.
Conclusions: Supplementation of the diet of the dams with 10% of oligofructose during pregnancy and lactation,
independent of supplementation with hydrogenated vegetable fat, adversely affected the development of the
offspring and contributed to development of a pro-inflammatory status in the pups on postnatal day 21.
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Maternal nutrition during the course of pregnancy and
during lactation plays a critical role in the development
of the fetus, newborn and future adult by epigenetic
modifications resulting in a metabolic imprint that induces
changes in phenotype. Recently, the concept of metabolic
programming has been applied to possible beneficial or
adverse influences of the maternal nutritional supply to
the fetus and newborn [1].
During fetal development, inadequate nutrition may alter
one or more aspects of physiological and morphological
development, which may increase the predisposition of
the individual for developing metabolic disorders [2-4].
Currently, it is known that there is a correlation between
the production of adipokines by adipose tissue and deve-
lopment of metabolic disorders [5].
Intake of hydrogenated vegetable fat, rich in trans
fatty acids (TFAs), during pregnancy and lactation
caused changes in the metabolism and decreased serum
adiponectin of the offspring assessed at 21 days after
birth. These changes were accompanied by increases in
gene expression of TNF-α and protein expression of
TRAF-6, a cytoplasmic protein associated with the toll-
like receptor 4 (TLR-4) pathway [6,7], in adipose tissue. It
has also been demonstrated that the consumption of TFAs
by rodents during lactation leads to metabolic disorders,
including insulin resistance and increased adipose tissue
gene expression of PAI-1 in the adult offspring. These
changes could increase the risk for thrombosis [8,9].
In this context, we demonstrated that increased hypo-
thalamic IL-6, TNF-α and IL1-β concentrations contributed
to hypothalamic inflammation and impaired satiety-sensing
in the offspring with deleterious consequences [10].
On the other hand, several studies in humans and
animals have confirmed that dietary fibers such as
oligofructose (OF), fructooligosaccharides (FOS) and
inulin influence glucose metabolism, specifically by redu-
cing glucose serum concentrations [11-14]. The authors
suggested that these dietary fibers affect the digestion and
absorption of the carbohydrates and starches [13] resulting
in a serum glucose-lowering effect [15,16], improved
glucose tolerance and increased insulin sensitivity [13].
Oligofructose, fructooligosaccharides and inulin are
members of the inulin-type fructans group. OF is the
combination of “non-digestible” oligosaccharides com-
monly obtained by partial enzymatic hydrolysis of chicory
root inulin, linked by ß (2→ 1) linkages of fructosyl units
sometimes ending with a glucosyl unit [13,17]. OF and
FOS are considered synonyms for inulin-type fructans
with a maximum degree of polymerization (DP) of less
than 10 [13]. In addition, due to the ß-configuration, OF
and other inulin-type fructans are hydrolyzed and
fermented by the colonic microbiota rather than being
digested in the upper gastrointestinal tract, with healthbenefits to the host [17-20]. Thus, the inulin-type fructans
are considered dietary fibers and prebiotics [17,20,21].
Hyperlipidic diets, especially those rich in saturated fatty
acid, increase endotoxemia by the promoting the trans-
location of lipopolysaccharides (LPS) from the membranes
of gram-negative intestinal bacteria [22,23]. LPS-induced
TLR-4 activation contributes to systemic inflammation
by inducing the secretion of pro-inflammatory cytokines
and chemokines. Prebiotics are fermented by the co-
lonic bacteria and can alter the intestinal environment
(bacterial population, intestinal permeability), thereby
reducing serum LPS concentrations [24].
During pregnancy and lactation, the maternal intake of
prebiotics and dietary fibers is considered important and
beneficial for the mother and the offspring, from birth
through adulthood. In particular, butyrate, the end-
product of oligosaccharide fermentation, is a histone
deacetylase inhibitor, which is believed to reactivate silent
genes by producing epigenetic modifications. These effects
on gene activity would be beneficial in the long term [1].
Moreover, a large variety of oligosaccharides are present in
human milk at concentrations ranging from 10 to 20 g/L
[25,26]. After lactose and fat, oligosaccharides are the
most abundant group of human milk components, poten-
tially preventing pathogen adhesion to the intestinal epi-
thelium, influencing the gut maturation process and the
intestinal microbiome, and modifying systemic functions
such as anti-inflammatory effects [25]. The aim of this
study was to evaluate the effect of the supplementation of
the diet of the dams with 10% oligofructose in the pres-
ence or absence of hydrogenated vegetable fat during
pregnancy and lactation on the pro-inflammatory status of
21-day-old pups.Materials and methods
Animals and treatments
The experimental research committee of the Universidade
Federal de São Paulo approved all procedures for the care
of the animals used in this study followed international
recognized guidelines (protocol n°2011/1907). The rats
were kept under controlled conditions of light (12-h light/
12-h dark cycle with lights on at 07:00) and temperature
(24 ± 1°C). Three-month-old female Wistar rats (4 animals
in each group) were left overnight to mate, and copulation
was verified the following morning by the presence of
sperm in vaginal smears.
On the first day of pregnancy, the dams were isolated in
individual cages and randomly divided into four groups,
each receiving one of four diets: a control diet (C diet, C
group), a control diet supplemented with oligofructose
(CF diet, CF group), a diet enriched with hydrogenated
vegetable fat (T diet, T group) or a diet enriched with hy-
drogenated vegetable fat supplemented with oligofructose
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out pregnancy and lactation.
The four diets were prepared according to the re-
commendations of the American Institute of Nutrition
(AIN- 93G) [27] and were similar in calories and lipid
content. The source of lipids for the C and CF diets was
soybean oil, and the principal source for the T and TF
diets were partially hydrogenated vegetable fat, which is
rich in TFAs. The CF and TF diets were prepared by
adding 100 g/kg diet of oligofructose (Orafti P95,
Pemuco, Chile). According to manufacturer, the OF
used in this study is a mixture of oligosaccharides
extracted from chicory root. These oligosaccharides are
composed of fructose units connected by ß (2–1) links.
Some of these molecules are terminated by a glucose
unit. The degree of polymerization (DP) of oligofructose
in this supplement ranges between 2 and 8.
The centesimal composition of the diets is presented
in Table 1. The fatty acid profile of C and T diets was
previously described by Pisani et al. [6].Table 1 Composition of the control diet, control diet
supplemented with oligofructose, diet enriched with
trans fatty acids and diet enriched with trans fatty acids
supplemented with oligofructose according to AIN-93
Diet (g/100g)
Ingredient C CF T TF
Casein* 20.0 20.0 20.0 20.0
L-cystine† 0.3 0.3 0.3 0.3
Cornstarch† 62.0 52.0 62.0 52.0
Soybean oil‡ 8.0 8.0 1.0 1.0
Hydrogenated vegetable fat$ - - 7.0 7.0
Butylhydroquinone† 0.0014 0.0014 0.0014 0.0014
Mineral mixture£ 3.5 3.5 3.5 3.5
Vitamin mixture# 1.0 1.0 1.0 1.0
Cellulose† 5.0 5.0 5.0 5.0
Choline bitartrate† 0.25 0.25 0.25 0.25
Oligofructose¢ - 10.0 - 10.0
Energy (kcal/g) 4.0 4.0 4.0 4.0
*Casein was obtained from Labsynth, São Paulo, Brazil.
†L-cystine, cornstarch, butylhydroquinone, cellulose and choline bitartrate
were obtained from Viafarma, São Paulo, Brazil.
‡Oil was supplied from soybean (Lisa/Ind. Brazil).
$Hydrogenated vegetable fat was supplied from Unilever, São Paulo, Brazil.
£Mineral mix 9mg/kg diet): calcium, 5000; phosphorus, 1561; potassium, 3600;
sodium, 1019; chloride, 1571; sulfur, 300; magnesium, 507; iron, 35; copper,
6.0; manganese, 10.0; zinc, 30.0; chromium, 1.0; iodine 0.2; selenium, 0.15;
fluoride, 1.00; boron, 0.50; molybdenum, 0.15; silicon, 5.0; nickel, 0.5; lithium,
0.1; vanadium, 0.1 (AIN-93G mineral mix, Rhoster, Brasil).
#Vitamin mix (mg/kg diet): thiamin HCL, 6.0, riboflavin, 6.0; pyridoxine HCL 7.0;
niacin, 30.0; calcium pantothenate, 16.0; folic acid, 2.0; biotin, 0.2; vitamin B12,
25.0; vitamin A palmitate 4000 IU; vitamin E acetate, 75; vitamin D3, 1000 IU;
vitamin KI, 0.75. (AIN-93G, vitamin mix, Rhoster, Brasil).
¢Oligofructose (P95) was manufactured by Orafti (Pemuco, Chile) and was
obtained by Viafarma, São Paulo, Brazil.On the day of delivery, considered day 0 of lactation,
litter sizes were adjusted to eight pups each. The pups
were weighed and measured (naso-anal length) at birth
and on postnatal days 7, 14 and 21.
Experimental procedures
The pups were decapitated on postnatal day 21. The ani-
mals were not fasted to avoid the weaning stress. Trunk
blood was collected and immediately centrifuged. The
serum was separated and stored at −80°C for later deter-
mination of glucose, insulin and adiponectin. The retro-
peritoneal (RET) white adipose tissue, liver, soleus (SOL)
and extensor digital longus (EDL) muscles were isolated,
weighed, immediately frozen in liquid nitrogen and stored
at −80°C.
Carcass lipid and protein content
The carcass lipid and protein content was determined in
the C, CF, T and TF rat pups. The carcasses were evis-
cerated, and the RET, epididymal and mesenteric white
adipose tissue, SOL, EDL and liver were removed. The
remaining carcasses were weighed and stored at −20°C.
The lipid content was measured as described by Stansbie
et al. [28] and standardized using the method described by
Oller do Nascimento and Williamson [29]. Briefly, the
eviscerated carcass was autoclaved at 120°C for 90 min
and homogenized with water at a volume twice the carcass
mass. Triplicate aliquots of this homogenate were weighed
and digested in 3 mL of 30% KOH and 3 mL of ethanol
for ≥2 h at 70°C in capped tubes. After cooling, 2 mL of
12 N H2SO4 was added, and the samples were washed
three times with petroleum ether to extract the lipids. The
results are expressed as grams of lipid per 100 g of carcass.
To measure the protein content, aliquots of the same
homogenate (approximately 1 g) were heated to 37°C for 1
h in 0.6 N KOH with constant shaking. After clarification
by centrifugation, the protein content was measured using
the Bradford assay (Bio-Rad, Hercules, California) with
bovine serum albumin as a reference.
Biochemical and hormonal serum analysis
The serum glucose concentrations were measured with a
commercial enzymatic colorimetric kit (Labtest, Brazil).
The insulin and adiponectin concentrations were quanti-
fied using specific enzyme-linked immunosorbent assay
(ELISA) kits (Linco Research, USA).
IL-6, IL-10 and TNF-α protein levels determined by ELISA
Following decapitation, portions of the RET (0.3 g), liver
(0.1 g), EDL and SOL (0.1 g) were homogenized in 800 μL
of chilled extraction buffer (100 mM Trizma Base pH 7.5;
10 mM EDTA; 100 mM NaF; 10 mM Na4P2O7; 10 mM
Na3VO4; 2 mM PMSF; 0.1 mg/ml aprotinin). After
homogenization, 80 μl of 10% Triton X-100 was added to
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nutes and then centrifuged (20817 g, 40 minutes, 4°C).
The supernatant was saved, and protein concentrations
were determined using the Bradford assay (Bio-Rad,
Hercules, California) with bovine serum albumin as a ref-
erence. Quantitative assessment of TNF-α, IL-6 and IL-10
proteins was carried out using ELISA (DuoSet ELISA,
R&D Systems, Minneapolis, MN, USA) following the rec-
ommendations of the manufacturer. All samples were run
in duplicate, and the mean value is reported.
Statistical analysis
All results are presented as the means ± standard error
of the mean (SE). The statistical significance of the dif-
ferences between the means of the four groups of sam-
ples was assessed using two-way analysis of variance
(ANOVA), followed by Tukey's test. Differences were
considered to be significant when p < 0.05.
Results
Body weight, body weight gain, length of the animal and
carcass lipid and protein content
The mean body weights (BWs) of the pups at birth were
similar among groups. However, the BWs of the 7-d-old
pups of the CF group were significantly lower (p = 0.0211)
than those of the C group. Similarly, the BWs of the 14-d-
old pups of the CF group were lower than those of the CFigure 1 (A) Body weight, (B) Length, (C) Body weight evolution and
CF - mothers fed control diet supplemented with oligofructose; T - mother
diet enriched with hydrogenated vegetable fat supplemented with oligofru
*p < 0.05, versus C. # p < 0.05, versus CF. & p < 0.05, versus T. $ p < 0.05, vers(p = 0.0195) and TF (p = 0.0005) groups. Finally, the BWs
of the 21-d-old CF and TF groups were significantly lower
than those of the C (p = 0.002; p = 0.0107, respectively)
and T (p = 0.0064; p = 0.0309, respectively) groups
(Figure 1A).
Regarding the BW gain, the CF group showed lower
gains in the first (p = 0.0233) and second (p = 0.0217)
weeks, compared to the C group. In the third week, the
BW gain in the CF group was significantly lower than the
C (p = 0.0112) and T (p = 0.0004) groups (Figure 1C).
Figure 1B shows that lengths of the pups in the CF
group were significantly lower at birth (p = 0.0315) and
at 14-d-old (p = 0.0198) than those of the C group at the
same time points. The lengths of the 21-d-old pups of
the CF and TF groups were lower than those of the C
(p < 0.0001; p = 0.0002, respectively) and T (p = 0.0003;
p = 0.0022, respectively) groups.
The relative carcass lipid content in the CF group was
significantly lower than the C (p = 0.0422) group. How-
ever, the relative carcass protein content was similar
among the C, CF, T and TF groups (Figure 1D).
Relative weight of tissues
The relative RET weight in the CF group was significantly
lower than that of the C (p < 0.0001) and T (p < 0.0001)
groups. There were no differences in relative liver weight
among groups. The relative SOL weight in the CF group(D) Carcass protein and lipid content. C - mothers fed control diet;
s fed diet enriched with hydrogenated vegetable fat; TF - mothers fed
ctose. Data are means ± SE of 8–14 determinations per group.
us TF.
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EDL weights of the CF and TF groups were lower than
those of the C (p = 0.0057; p = 0.0132) and T (p = 0.0021;
p = 0.0051) groups (Table 2).
Serum glucose, adiponectin and insulin concentrations
The serum concentrations of glucose and insulin of the
pups at 21-d-old were similar among all groups. However,
the serum levels of adiponectin were significantly lower in
the CF (p < 0.0001), T (p = 0.0013) and TF (p = 0.0038)
groups compared with the C group (Table 3).
Tissues cytokine content
Figure 2A shows that the IL-6 content in the RET was
greater in the TF group than in the C (p = 0.0203) and
CF (p = 0.0106) groups. In other tissues, the IL-6 content
was not significantly different among the C, CF, T and
TF groups.
The IL-10 content in the liver was greater in the CF
group than in the C (p = 0.0041) and TF (p = 0.0021)
groups. In RET, SOL and EDL, the IL-10 content did
not differ among the groups (Figure 2B).
The TNF-α content of the livers of the CF group was
greater than that of the C (p = 0.0027) and TF (p = 0.0005)
groups. In RET, the TNF-α content in the T (p = 0.0462)
and TF (p = 0.0037) groups was greater than that of the C
group (Figure 2C).
The IL-10/TNF-α ratio was lower in SOL of the TF
group compared to the T (p = 0.0073) group (Figure 2D),
but not in any other tissues or groups.
Discussion
In the present study, supplementation of the dams diet
with 10% oligofructose during pregnancy and lactation
reduced the body weight, body weight gain, length and
lipid carcass content; increased levels of TNF-α and IL-6;
and decreased the serum levels of adiponectin of the pups.
These results indicate that supplementation of the dam’s
diet with a high oligofructose content (10%) induced a
pro-inflammatory state in the offspring.Table 2 Relative weight of tissues adipose retroperitoneal
(RET), soleus (SOL) and long extensor digit (EDL) muscles
and liver in pups with 21 days
Relative weight
(g/100g b.w.)
C (9) CF (10) T (9) TF (9)
RET 0.45 ± 0.04 0.27 ± 0.04*,& 0.45 ± 0.04 0.33 ± 0.02
Liver 3.31 ± 0.06 3.13 ± 0.08 3.27 ± 0.06 3.44 ± 0.08
SOL 0.07 ± 0.00 0.06 ± 0.00& 0.07 ± 0.00 0.06 ± 0.00
EDL 0.07 ± 0.00 0.06 ± 0.00*,& 0.07 ± 0.00 0.06 ± 0.00*,&
C - mothers fed control diet; CF - mothers fed control diet supplemented with
oligofructose; T - mothers fed diet enriched with hydrogenated vegetable fat;
TF - mothers fed diet enriched with hydrogenated vegetable fat
supplemented with oligofructose. The number in parentheses refers to the
sample value. Data are means ± SE. *p < 0.05, versus C. & p < 0.05, versus T.The 21-d-old pups of the CF and TF groups had lower
body weights and lengths compared to those of the C
and T groups. The body weight and length effects were
accompanied by a reduction in the relative weights of
the RET, SOL and EDL. Decreased body weight gain was
also observed in the pups of the CF group throughout
the experimental period.
Previous studies regarding the effect of high fiber diets
during pregnancy and lactation indicate controversy in
the field. In agreement with our results, Carabin and
Flamm reported that the ingestion of diet containing
20% FOS during pregnancy and lactation caused a delay
in the growth of the pups [13].
In contrast, other studies did not report negative effects
of FOS supplementation during pregnancy on the devel-
opment of offspring [13,30]. Furthermore, Pisani et al.
previously reported that trans fatty acid intake during
pregnancy and lactation did not modify the body weight
of the pups during the entire period of lactation. In our
study, the birth weights were not affected either by a trans
fatty acid diet or 10% OF supplementation during preg-
nancy [6]. Maurer et al. showed no differences in the
birth weight or subsequent body weights of the pups at
7, 14, or 21 days after birth from dams fed with control,
high fiber (a combination of the prebiotic fibers inulin
and oligofructose) or high protein diet during pregnancy
and lactation. Similarly, Rodenburg et al. reported no
difference in body weight gain of eight-week-old rats fed
a control diet or one containing 6% of FOS [31,32].
In addition, the change in weight gain and reduced
carcass lipid content found in the CF group compared to
the C group is consistent with the hypothesis that off-
spring of dams fed a diet supplemented with high amount
of oligofructose suffer from malnutrition. Taken together,
these results suggest that the amount and type of prebiotic
ingested as well as the period during which the animal is
exposed could influence the development of the animal.
Trans fatty acid intake during pregnancy and lactation
increased the TNF-α content in the pup’s RET. Previously,
it has been shown that ingestion of hydrogenated vege-
table fat rich in TFAs during these periods decreased
AdipoR1 and elevated TRAF-6 protein expression in the
RET of 21-d-old offspring. PAI-1 and TNF-α gene expres-
sion was also increased, while the serum adiponectin levels
decreased [7,9]. Furthermore, TNF-α gene expression in
adipose tissue has been shown to correlate with circulating
TNF-α levels [33].
The oligofructose supplementation did not alter the in-
flammatory effect of the trans fatty acids. In fact, the ana-
lysis of the IL-6 content in RET suggested that the addition
of OF seemed to increase the inflammatory effect of
trans fatty acids. On the other hand, the supplementa-
tion of control diet with OF (10%) during pregnancy
and lactation caused an increase in TNF-α and IL-10 in
Table 3 Serum glucose, adiponectin and insulin in pups with 21 days
C CF T TF
Glucose (mg/dL) 107.95 ± 3.43 (9) 116.03 ± 5.38 (10) 112.07 ± 3.92 (9) 119.82 ± 3.22 (9)
Adiponectin (μg/mL) 24.13 ± 3.64 (16) 14.12 ± 1.52* (16) 15.89 ± 2.02* (16) 16.59 ± 2.36* (16)
Insulin (ng/mL) 0.23 ± 0.02 (9) 0.27 ± 0.03 (10) 0.30 ± 0.04 (10) 0.35 ± 0.03 (9)
C - mothers fed control diet; CF - mothers fed control diet supplemented with oligofructose; T - mothers fed diet enriched with hydrogenated vegetable fat;
TF - mothers fed diet enriched with hydrogenated vegetable fat supplemented with oligofructose. The number in parentheses refers to the sample value. Data
are means ± SE. *p < 0.05, versus C.
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onment was accompanied by a reduction in the plasma
adiponectin concentrations in CF, T and TF. Adiponectin
increases insulin sensitivity and has anti-inflammatory and
anti-atherogenic effects [34]. In the literature, increased
TNF-α concentrations were reported to be associatedFigure 2 (A) IL-6 content in adipose retroperitoneal (RET), soleus (SOL
RET, SOL, EDL and liver, (C) TNF-α content in RET, SOL, EDL and liver
fed control diet; CF - mothers fed control diet supplemented with oligofru
TF - mothers fed diet enriched with hydrogenated vegetable fat suppleme
per group. *p < 0.05, versus C. # p < 0.05 versus CF. & p < 0.05, versus T. $ p <with a decrease in the expression and secretion of adi-
ponectin [35,36].
In a review, Roberfroid reported several studies that
identified health benefits of FOS in animals and humans
and addressed possible intolerance [21]. These studies
demonstrated that the symptoms are dose-dependent:), long extensor digit (EDL) muscle and liver, (B) IL-10 content in
and (D) IL-10/TNF-α ratio in RET, SOL, EDL and liver. C - mothers
ctose; T - mothers fed diet enriched with hydrogenated vegetable fat;
nted with oligofructose. Data are means ± SE of 6–17 determinations
0.05 versus TF.
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or more in humans.
In our study, the supplementation of diet with 10% OF
during pregnancy and lactation caused diarrhea in dams
(data not shown). This effect could have contributed to
development of pro-inflammatory environment observed
in the offspring. Bruggencate et al. studied supplementa-
tion with 3% or 6% of FOS and found that the supple-
ment impaired resistance to intestinal infections, with
dose-dependent increases in the colonization and trans-
location of Salmonella enteritidis [37]. In addition, FOS
decreased cecal and fecal pH in a dose-dependent manner.
Altered pH in these compartments can contribute to im-
pairment of the intestinal mucosal barrier through colonic
mucosal damage and/or inflammation associated with the
rapid production of the short chain fatty acids (SCFA)
and/or lactate (organic acids). Moreover, Rodenburg et al.
reported that the intake of FOS by rats harmed the
barrier integrity by increasing mucosal permeability,
bacterial translocation and expression of colonic mito-
chondrial genes that may be involved in the mainten-
ance of the intestinal barrier [32]. FOS stimulates the
growth, not only of potentially beneficial bacterial species
including bifidobacteria and enterobacteria but also of
potential pathogens [37]. It is also possible that the oligo-
saccharides presents in maternal milk [25] can lead to
excessive production of organic acids in the gut of pups,
altering the intestinal permeability and microbiome com-
position in the offspring [32,37]. Thus, an alteration of
bacterial population and an increase in bacterial transloca-
tion and intestinal permeability could cause an increase
in serum LPS, resulting in TLR4-mediated inflammatory
responses [24].
Conclusion
In conclusion, supplementation of the diet of the dams
with oligofructose (10%) during pregnancy and lactation,
in the presence or absence of supplementation with hy-
drogenated vegetable fat, adversely affected the develop-
ment of the offspring and contributed to increases in the
pro-inflammatory status in pups at postnatal day 21.
Further studies are needed in this area to examine the
dose-dependent effects of the oligofructose on metabolic
programming.
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